Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Prelude Therapeutics (PRLD) Other Gross PP&E Adjustments (2024 - 2025)

Prelude Therapeutics' Other Gross PP&E Adjustments history spans 2 years, with the latest figure at -$8.9 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 133.36% year-over-year to -$8.9 million; the TTM value through Dec 2025 reached -$8.9 million, down 133.36%, while the annual FY2025 figure was -$8.9 million, 133.36% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$8.9 million at Prelude Therapeutics, up from -$27.9 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at -$583000.0 in Q2 2024 and bottomed at -$30.1 million in Q1 2024.